Objective: To proliferation in patients with liver cancer. Methods: Patients with primary liver cancer who underwent surgical resection in Yulin Third Hospital between December 2013 and December 2016 were selected as the liver cancer group of the research, and healthy volunteers who received physical examination in Yulin Third Hospital over the same period were selected as the control group of the research. Serum was collected from both groups to test the contents of ASPH and 5'-NT as well as

more »

... ver cancer cell proliferation molecules; liver cancer lesions and para-carcinoma lesions were collected from liver cancer group to detect the contents of angiogenesis molecules and cancer cell proliferation molecules. Results: Serum ASPH and 5'- NT contents in liver cancer group were significantly higher than those in control group; VEGF, VEGFR1, VEGFR2, HGF, EGFR, Bcl-2, Bcl-x and Bcl-w contents in liver cancer lesions were significantly higher than those in para-carcinoma lesions and positively correlated with serum ASPH and 5'-NT contents in patients with liver cancer while Bax and Bak contents in liver cancer lesions were significantly lower than those in para-carcinoma lesions and negatively correlated with serum ASPH and 5'-NT contents in patients with liver cancer; serum AFP, GP73, GPC3 and DKK1 contents in liver cancer group were significantly higher than those in control group and positively correlated with serum ASPH and 5'-NT contents in patients with liver cancer. Conclusion: Serum ASPH and 5'-NT contents increase significantly in patients with liver cancer and can accurately evaluate angiogenesis and cancer cell proliferation.